The gene-editing revolution promises cures for terminal diseases and new approaches to fighting climate change. However, these new genetic technologies also bring significant ethical and practical risks, sparking debates about who belongs and who doesn't, and who decides which risks are worth taking.

Professor James Dale is working to save the Cavendish banana, the world's most popular variety, from extinction due to Tropical Race 4 (TR4), a deadly disease. He has engineered a genetically modified (GM) banana resistant to TR4, but faces significant public resistance to GM crops, particularly in Europe. This resistance presents an ethical dilemma, hindering the development of crops that could be crucial for food security in a changing climate.

In Islamorada, genetically modified mosquitoes are being released to combat Zika and dengue fever. However, local communities have voiced strong opposition, leading to secret release locations. Bioethicist Natalie Koffler raises concerns about the lack of transparent regulation and community consent in such projects, fearing that inadequate engagement could lead to greater distrust in beneficial genetic technologies.

The development of CRISPR, a gene-editing technique that won a Nobel Prize in 2020, has made precise DNA editing cheaper and easier. CRISPR allows for targeted cuts in gene sequences, offering the potential to tackle genetic diseases more effectively, similar to how the Ford Model T made cars accessible to everyone.

CRISPR holds immense promise for treating genetic diseases like sickle cell anemia. Josh Lehrer of Graphite Bio is researching CRISPR-based cures, aiming for a 'find and replace' approach to correct genetic defects. However, the use of gene editing becomes ethically complex when considering its application for non-disease traits like eye or skin color, raising difficult questions about 'designer humans'.

In Moscow, scientists are using CRISPR to try to eliminate hereditary deafness, a prospect that deeply troubles many in the deaf community who see it as a threat to their culture and identity. The concept of 'designer humans' and the ethical implications of altering human traits are highlighted. Germline editing, which causes genetic changes to be passed down through generations, is especially controversial. The 2018 incident where a Chinese scientist edited embryos to confer HIV immunity sparked global outrage and led to calls for a moratorium on germline editing.

Regulation of gene-edited plants varies globally. Some countries treat gene-edited produce differently from older GM varieties, which often contain foreign DNA. While the EU bans gene-edited food, it's available in Japan and the US. This permissive regulation raises concerns about the potential for unmonitored 'wild experiments' and emphasizes the need for better regulatory frameworks. James Dale is using CRISPR to develop a disease-resistant banana without foreign DNA, hoping to bypass strict GM regulations.

CRISPR offers significant potential for addressing climate change by developing more climate-tolerant crops. Beyond plants, gene editing is even being explored for animals. At Pleistocene Park, scientists are attempting to 'de-extinct' woolly mammoths by editing elephant genes. The aim is to repopulate Siberia with these animals to help combat global warming by compacting snow and preserving permafrost. Critics, however, worry that such headline-grabbing projects might distract from more pressing conservation issues.

Gene editing has the potential to transform life on Earth. As scientists and society grapple with the rewards and risks, there's a critical need to distinguish between irrational fear of the new and genuine ethical concerns. The video concludes by emphasizing the importance of aligning scientific advancements with ethical aspirations for the world.